279 related articles for article (PubMed ID: 29730199)
1. Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of Followup.
Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
J Urol; 2018 Oct; 200(4):794-800. PubMed ID: 29730199
[TBL] [Abstract][Full Text] [Related]
2. Long-term sexual functioning in germ-cell tumor survivors.
Chovanec M; Vasilkova L; Petrikova L; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M
BMC Cancer; 2020 Aug; 20(1):779. PubMed ID: 32819309
[TBL] [Abstract][Full Text] [Related]
3. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
7. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
8. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
9. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT).
Ann Oncol; 2001 Sep; 12(9):1215-6. PubMed ID: 11697829
[No Abstract] [Full Text] [Related]
10. Management of stage I testicular germ cell tumours.
Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
[TBL] [Abstract][Full Text] [Related]
11. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
13. Chronic pain has a negative impact on sexuality in testis cancer survivors.
Pühse G; Wachsmuth JU; Kemper S; Husstedt IW; Evers S; Kliesch S
J Androl; 2012; 33(5):886-93. PubMed ID: 21474790
[TBL] [Abstract][Full Text] [Related]
14. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer.
Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
Eur Urol Focus; 2020 Jul; 6(4):711-719. PubMed ID: 30482585
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
16. Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Lauritsen J; Kier MG; Mortensen MS; Bandak M; Gupta R; Holm NV; Agerbaek M; Daugaard G
J Clin Oncol; 2015 Oct; 33(28):3116-23. PubMed ID: 26240225
[TBL] [Abstract][Full Text] [Related]
17. Objective and subjective effects of treatment for testicular cancer on sexual function.
van Basten JP; van Driel MF; Hoekstra HJ; Sleijfer DT; van de Wiel HB; Droste JH; Schraffordt Koops H; Mensink HJ
BJU Int; 1999 Oct; 84(6):671-8. PubMed ID: 10510114
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.
van Basten JP; Hoekstra HJ; van Driel MF; Koops HS; Droste JH; Jonker-Pool G; van de Wiel HB; Sleijfer DT
J Clin Oncol; 1997 Jun; 15(6):2442-8. PubMed ID: 9196160
[TBL] [Abstract][Full Text] [Related]
19. Delivery of chemotherapy for testicular cancer in routine practice: A population-based study.
Karim S; Wei X; Leveridge MJ; Siemens DR; Robinson AG; Bedard PL; Booth CM
Urol Oncol; 2019 Mar; 37(3):183.e17-183.e24. PubMed ID: 30478011
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
